B
Research Areas
Biography and Research Information
OverviewAI-generated summary
Benjamin Rougeau's research focuses on the design, synthesis, and development of novel chemical compounds. His recent publication in 2026 details the creation of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol, a compound engineered as a dual inhibitor for fatty acid biosynthesis (FASII) with the goal of clearing Methicillin-resistant Staphylococcus aureus (MRSA) infections. Rougeau has published three papers to date, accumulating 42 citations and an h-index of 2. He has collaborated with several researchers at Arkansas State University, including Mohammad A. Alam, Fabricio Medina-Bolívar, Gaurav Gajurel, and Robert C. Shields, with whom he shares one publication each.
Metrics
- h-index: 2
- Publications: 3
- Citations: 42
Selected Publications
-
Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection (2026)
Collaboration Network
Top Collaborators
Mohammad A. Alam
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Shailesh Budhathoki
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Justin Roberts
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Subrata Roy
Arkansas State University (US)
1 shared publication
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Hideya Koizumi
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Gaurav Gajurel
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Fabricio Medina-Bolívar
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Jonathan Merten
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Mohamed Milad
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Alexei G. Basnakian
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Robert C. Shields
Arkansas State University
1 shared publication
In database
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Similar Researchers
Based on overlapping research topics
Gregory R. Naumiec
University of Central Arkansas
Drug Delivery Systems
Metabolism and Genetic Disorders
Microbial infections and disease research
Jacob M Kaufman
University of Arkansas at Fayetteville
Metabolism and Genetic Disorders
Microbial infections and disease research
Bacterial Genetics and Biotechnology
Jackeline Rodriguez‐Smith
University of Arkansas for Medical Sciences
Microbial infections and disease research
Bacterial Genetics and Biotechnology
Computational Drug Discovery Methods
Ifedi Orizu
University of Arkansas at Fayetteville
Metabolism and Genetic Disorders
Computational Drug Discovery Methods
Synthesis and biological activity
Mark Smeltzer
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Microbial infections and disease research
Bacterial Genetics and Biotechnology
Jessica L. Kelliher
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Microbial infections and disease research
Bacterial Genetics and Biotechnology